Related Experiment Video
Updated: Mar 6, 2026
Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
Elaine M Waters1, Daniel R Neill1, Basak Kaman1
1Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Abstract:
With an increase in cases of multidrug-resistant Pseudomonas aeruginosa, alternative and adjunct treatments are needed, leading to renewed interest in bacteriophage therapy. There have been few clinically relevant studies of phage therapy against chronic lung infections. Using a novel murine model that uses a natural respiratory inhalation route of infection, we show that phage therapy is an effective treatment against chronic P. aeruginosa lung infections. We also show efficacy against P. aeruginosa in a biofilm-associated cystic fibrosis lung-like environment. These studies demonstrate the potential for phage therapy in the treatment of established and recalcitrant chronic respiratory tract infections.
Insights
Bacteriophage therapy effectively treats chronic Pseudomonas aeruginosa lung infections in a new mouse model. This approach shows promise for difficult-to-treat respiratory infections, including those in cystic fibrosis environments.
Area of Science:
- Microbiology
- Infectious Diseases
- Pulmonary Medicine
Background:
- Rising multidrug-resistant *Pseudomonas aeruginosa* necessitates novel therapeutic strategies.
- Bacteriophage therapy is gaining traction as an alternative or adjunct treatment.
- Limited clinical data exists for phage therapy in chronic lung infections.
Discussion:
- A novel murine model with natural respiratory infection route was utilized.
- Phage therapy demonstrated efficacy against chronic *P. aeruginosa* lung infections.
- Efficacy was also observed in a cystic fibrosis lung-like biofilm environment.
Key Insights:
- Phage therapy is a viable treatment for established *P. aeruginosa* lung infections.
- The study validates phage therapy in a clinically relevant biofilm model.
- This research supports phage therapy for recalcitrant chronic respiratory infections.
Outlook:
- Further clinical investigation of bacteriophage therapy for chronic lung infections is warranted.
- Phage therapy holds potential for treating cystic fibrosis-associated lung infections.
- This study paves the way for developing phage-based treatments against resistant bacterial pathogens.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:28Gene Regulation in Microbial Communities: Quorum Sensing
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....